Latest News & Features
Europe
The EPO's approach to claim interpretation has shifted significantly following the G1/24 decision. This session unpacks how Technical Boards of Appeal are newly applying the mandate to consult descriptions and drawings, and what this means for drafting and opposition strategy. 26 May 2026
Americas
What is the most effective way to allocate patent activities between in-house teams and external counsel? This panel explores strategies for maximising ROI, controlling costs, and fostering seamless collaboration across internal scientists, legal teams, and service providers. 25 May 2026
Asia
The regulatory and IP environment in China is shifting at a rapid pace, bringing new measures, guiding cases, and compliance hurdles. This session provides a high-level overview of the past year’s critical changes and what life sciences companies must anticipate on the horizon. 24 May 2026
Unified Patent Court
Managing parallel revocation actions requires a meticulous approach to forum choice and sequencing. This presentation unpacks the lessons learned from the first year of simultaneous EPO and UPC proceedings, offering tactics to leverage opportunities and minimise cross-border risks. 23 May 2026
Americas
A US appeals court has handed the generic drugmaker victory in a closely watched dispute over a treatment for a serious inherited kidney condition, dealing a setback to its branded rival. 22 May 2026
Americas
How can innovators secure reliable protection across diagnostics, genetics, and AI-integrated devices while navigating Section 101 and 112 pitfalls? This comprehensive panel addresses strategies to clear fundamental patentability hurdles amid shifting court decisions and USPTO guidelines. 22 May 2026
Americas
European officials have again sided with Glenmark, concluding that the 3D mark for Boehringer’s HandiHaler device is ineligible for registration. 21 May 2026
Europe
The court has imposed a financial penalty after finding it continued promoting banned devices online despite an injunction covering five European countries. 21 May 2026
Americas
The rapid evolution of CRISPR and base editing brings transformative medical potential alongside deeply complex IP and licensing hurdles. This session explores how companies can balance innovation with risk mitigation in a crowded and highly contested precision medicine landscape. 21 May 2026
Asia
Backed by the country’s wider AI ambitions, Google has signed a deal to roll out healthcare, scientific research, and safety initiatives. 20 May 2026